The Hh signaling pathway appears to play a critical role in promoting cell proliferation and angiogenesis (50, 51), while PHD2 inhibition can activate the Hh signaling pathway via the GPT2-α-KG-PHD2 axis in breast cancer (52). The gene discussed is EGLN1; the disease is breast cancer.